Physician Assistant in Grandview, MO Accepting Medicare
4 Physician Assistant nurses found. Showing 1 - 4
 Madison Rae Newell, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 7201 E 147th St, Grandview, MO 64030 Phone: 816-348-2260 Fax: 913-495-3751 |
 Saurav N Kayastha, MD, AP Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave Ste A, Grandview, MO 64030 Phone: 816-214-5548 |
Dr. Alfred A. Viyuoh, MD Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave, Grandview, MO 64030 Phone: 816-214-5548 |
Dr. Mahmoud B. T. Algharabli, MD Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave Ste A, Grandview, MO 64030 Phone: 816-214-5548 |
News Archive
NIHR HPRU announces new round of funding to support Zika virus research
A round of funding to support research on the emerging Zika virus was announced this week by the National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections at the University of Liverpool.
Depomed third quarter 2012 revenue increases to $33.3 million
Depomed, Inc. today reported financial results for the quarter and nine months ended September 30, 2012.
Financial investment, progress in HIV/AIDS treatment must be protected by international patent law
In this Hill opinion piece, John Castellani, CEO and president of the Pharmaceutical Research and Manufacturers of America, writes, "Over the past three decades, more than 30 treatments have been approved to treat HIV/AIDS," but he adds, "While this is remarkable progress, it's not enough."
Intellipharmaceutics International files Protonix ANDA with FDA
Intellipharmaceutics International Inc. today announced that is has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for a generic of Protonix® (delayed release pantoprazole sodium). Protonix inhibits gastric acid secretion and is prescribed for the short-term treatment of conditions such as stomach ulcers associated with gastroesophageal reflux disease as well as the long term treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome.
Technology that could double the effectiveness of cancer drugs
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology called the ChemoFX assay, which could double the response rate to existing drugs.
› Verified 5 days ago
Nurse Practitioner
Registered Nurse
Physician Assistant
Licensed Practical Nurse